ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases.
作者信息
Ikizler T Alp, Kramer Holly J, Beddhu Srinivasan, Chang Alex R, Friedman Allon N, Harhay Meera N, Jimenez Elizabeth Yakes, Kistler Brandon, Kukla Aleksandra, Larson Kristin, Lavenburg LindaMarie U, Navaneethan Sankar Dass, Ortiz John, Pereira Rocio I, Sarwer David B, Schauer Philip R, Zeitler Evan M
机构信息
Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Nephrology and Hypertension, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.
出版信息
J Am Soc Nephrol. 2024 Nov 1;35(11):1574-1588. doi: 10.1681/ASN.0000000512. Epub 2024 Sep 18.
Abstract
摘要
相似文献
1
ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases.美国肾脏病学会（ASN）关于肾脏病患者肥胖管理的健康指南。
J Am Soc Nephrol. 2024 Nov 1;35(11):1574-1588. doi: 10.1681/ASN.0000000512. Epub 2024 Sep 18.
2
SEN, SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification.SEN、SLANH和SEEDO关于肥胖相关肾病的共识报告：新分类建议
Kidney Int. 2025 Jul 3. doi: 10.1016/j.kint.2025.06.013.
3
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.钠-葡萄糖共转运蛋白 2（SGLT-2）抑制剂治疗慢性肾脏病成人患者：临床实践指南。
BMJ. 2024 Oct 1;387:e080257. doi: 10.1136/bmj-2024-080257.
4
A Systematic Review of Barriers and Facilitators of Pain Management in Persons with Dementia.痴呆症患者疼痛管理的障碍和促进因素的系统评价。
J Pain. 2023 May;24(5):730-741. doi: 10.1016/j.jpain.2022.12.014. Epub 2023 Jan 9.
5
Improving Diet Quality of People Living With Obesity by Building Effective Dietetic Service Delivery Using Technology in a Primary Health Care Setting: Protocol for a Randomized Controlled Trial.通过在初级卫生保健环境中利用技术建立有效的饮食服务提供来改善肥胖症患者的饮食质量：一项随机对照试验方案
JMIR Res Protoc. 2025 Apr 30;14:e64735. doi: 10.2196/64735.
7
"It doesn't get more normal than that!" - challenges with sexuality experienced by people with neuromuscular diseases and their needs for rehabilitation knowledge and guidance on sexual life.“再正常不过了！”——神经肌肉疾病患者在性方面所经历的挑战以及他们对性康复知识和性生活指导的需求
Disabil Rehabil. 2025 Aug;47(16):4127-4136. doi: 10.1080/09638288.2024.2440635. Epub 2024 Dec 18.
8
Gender-affirming Hormone Therapy and Changes in Kidney Function in Adults: A Retrospective Population-based Study.成人性别肯定激素治疗与肾功能变化：一项基于人群的回顾性研究。
Kidney Med. 2025 Jun 17;7(8):101051. doi: 10.1016/j.xkme.2025.101051. eCollection 2025 Aug.
9
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历：一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
10
Digital health, technology-driven or technology-assisted interventions for the management of obesity in children and adolescents.数字健康，即用于管理儿童和青少年肥胖症的技术驱动或技术辅助干预措施。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015968. doi: 10.1002/14651858.CD015968.
引用本文的文献
1
Low-Energy Diets: Potential Treatment Option for Patients With Obesity and Early-Stage CKD?低能量饮食：肥胖和早期慢性肾脏病患者的潜在治疗选择？
Kidney Int Rep. 2025 May 17;10(7):2088-2090. doi: 10.1016/j.ekir.2025.05.018. eCollection 2025 Jul.
2
Practices in the management of kidney transplant candidates and recipients with obesity: A survey of United States transplant programs.肥胖肾移植候选者及受者的管理实践：美国移植项目调查
Am J Transplant. 2025 May 31. doi: 10.1016/j.ajt.2025.05.033.
3
Obesity and its management in primary care setting.肥胖症及其在基层医疗环境中的管理。
J Diabetes Complications. 2025 Jul;39(7):109045. doi: 10.1016/j.jdiacomp.2025.109045. Epub 2025 Apr 19.
4
Obesity and Metabolic Health in CKD.慢性肾脏病中的肥胖与代谢健康
Clin J Am Soc Nephrol. 2025 May 1;20(5):742-754. doi: 10.2215/CJN.0000000704. Epub 2025 Mar 14.
本文引用的文献
1
Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients with Established Kidney Disease.代谢手术与 GLP1 受体激动剂对已患有肾脏疾病患者的肾脏损害进展的肾脏保护作用比较。
Ann Surg. 2024 Sep 1;280(3):414-423. doi: 10.1097/SLA.0000000000006379. Epub 2024 Jun 11.
2
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial.SELECT 试验中司美格鲁肽在肥胖和心血管疾病中的长期肾脏结局。
Nat Med. 2024 Jul;30(7):2058-2066. doi: 10.1038/s41591-024-03015-5. Epub 2024 May 25.
3
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.司美格鲁肽对 2 型糖尿病患者慢性肾脏病的影响。
N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.
4
Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity.肥胖合并肾衰竭患者行减重手术后移植肾存活率增加。
Mayo Clin Proc. 2024 May;99(5):705-715. doi: 10.1016/j.mayocp.2024.01.017.
5
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
6
Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.2 型糖尿病的医学管理与减重手术的长期结果比较。
JAMA. 2024 Feb 27;331(8):654-664. doi: 10.1001/jama.2024.0318.
7
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.恩格列净对 CKD 患者液体超负荷、体重和血压的影响。
J Am Soc Nephrol. 2024 Feb 1;35(2):202-215. doi: 10.1681/ASN.0000000000000271. Epub 2023 Dec 12.
8
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024.10. 心血管疾病与风险管理：2024年糖尿病护理标准。
Diabetes Care. 2024 Jan 1;47(Suppl 1):S179-S218. doi: 10.2337/dc24-S010.
9
Nutritional Considerations for Patients With Renal Failure Undergoing Sleeve Gastrectomy.肾衰竭患者行袖状胃切除术的营养考虑。
J Ren Nutr. 2024 Jan;34(1):76-86. doi: 10.1053/j.jrn.2023.08.005. Epub 2023 Aug 19.
10
Comparative outcomes of bariatric surgery in patients with ESRD on dialysis in the modern era of renal transplantation: analysis using the 2015-2020 MBSAQIP database.在肾移植的现代时代，比较接受透析的 ESRD 患者行减肥手术的结果：利用 2015-2020 年 MBSAQIP 数据库进行的分析。
Surg Endosc. 2023 Sep;37(9):7106-7113. doi: 10.1007/s00464-023-10200-z. Epub 2023 Jul 3.
Zotero 插件